Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.

Yuan JM, Fan Y, Ognjanovic S, Wang R, Van Den Berg D, Govindarajan S, Yu MC.

BMC Gastroenterol. 2013 Feb 18;13:32. doi: 10.1186/1471-230X-13-32.

PMID:
23419149
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.

Wu J, Zhang W, Xu A, Zhang L, Yan T, Li Z, Wu X, Zhu X, Ma J, Li K, Li H, Liu Y.

Genet Test Mol Biomarkers. 2013 Aug;17(8):595-600. doi: 10.1089/gtmb.2013.0031. Epub 2013 Jun 22.

PMID:
23790025
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.

Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H.

Liver Int. 2010 Jan;30(1):112-8. doi: 10.1111/j.1478-3231.2009.02134.x. Epub 2009 Oct 15.

PMID:
19840254
[PubMed - indexed for MEDLINE]
4.

Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA.

Ognjanovic S, Yuan JM, Chaptman AK, Fan Y, Yu MC.

Carcinogenesis. 2009 May;30(5):758-62. doi: 10.1093/carcin/bgn286. Epub 2009 Jan 6.

PMID:
19126646
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.

Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, O'Brien TR, Dienstag JL, Tanabe KK, Chung RT; HALT-C Trial Group.

Gastroenterology. 2011 Jul;141(1):141-9. doi: 10.1053/j.gastro.2011.03.045. Epub 2011 Mar 24.

PMID:
21440548
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.

Zhong JH, You XM, Gong WF, Ma L, Zhang Y, Mo QG, Wu LC, Xiao J, Li LQ.

PLoS One. 2012;7(3):e32159. doi: 10.1371/journal.pone.0032159. Epub 2012 Mar 5.

PMID:
22403631
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.

Abbas E, Shaker O, Abd El Aziz G, Ramadan H, Esmat G.

Eur J Gastroenterol Hepatol. 2012 Apr;24(4):458-63. doi: 10.1097/MEG.0b013e3283508d45.

PMID:
22293333
[PubMed - indexed for MEDLINE]
8.

Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.

Yang Z, Wu Q, Shi Y, Nie Y, Wu K, Fan D.

Genet Test Mol Biomarkers. 2012 Sep;16(9):1086-91. doi: 10.1089/gtmb.2012.0050. Epub 2012 Aug 1.

PMID:
22852842
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.

Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC.

JAMA. 2008 Jan 2;299(1):53-60. doi: 10.1001/jama.2007.65.

PMID:
18167406
[PubMed - indexed for MEDLINE]
10.

+49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.

Gu X, Qi P, Zhou F, Ji Q, Wang H, Dou T, Zhao Y, Gao C.

Hum Immunol. 2010 Jan;71(1):83-7. doi: 10.1016/j.humimm.2009.09.353. Epub .

PMID:
19778566
[PubMed - indexed for MEDLINE]
11.

Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.

Chen K, Wei Y, Yang H, Li B.

Genet Test Mol Biomarkers. 2011 Apr;15(4):251-5. doi: 10.1089/gtmb.2010.0208. Epub 2010 Dec 27.

PMID:
21186997
[PubMed - indexed for MEDLINE]
12.

No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.

Qi P, Wang H, Chen YM, Sun XJ, Liu Y, Gao CF.

Pathology. 2009;41(6):555-60.

PMID:
19900104
[PubMed - indexed for MEDLINE]
13.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025. Epub 2011 Oct 12.

PMID:
22019522
[PubMed - indexed for MEDLINE]
14.

Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Yuan JM, Govindarajan S, Arakawa K, Yu MC.

Cancer. 2004 Sep 1;101(5):1009-17.

PMID:
15329910
[PubMed - indexed for MEDLINE]
Free Article
15.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
[PubMed - indexed for MEDLINE]
Free Article
16.

Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.

Koh WP, Yuan JM, Wang R, Govindarajan S, Oppenheimer R, Zhang ZQ, Yu MC, Ingles SA.

Cancer. 2011 Aug 1;117(15):3383-92. doi: 10.1002/cncr.25939. Epub 2011 Feb 11.

PMID:
21319151
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.

de Mello RA, Ferreira M, Costa S, Costa BM, Pires FS, Neves I, Almeida MI, Cunha J, Oliveira P, Hespanhol V, Reis RM.

Tumour Biol. 2012 Oct;33(5):1341-8. doi: 10.1007/s13277-012-0382-7. Epub 2012 Mar 29.

PMID:
22457050
[PubMed - indexed for MEDLINE]
18.

Association between EGF +61 G/A and glioma risk in a Chinese population.

Wang S, Zhao Y, Ruan Z, Chen H, Fan W, Chen J, Wu Q, Qian J, Zhang T, Huang Y, Lu D.

BMC Cancer. 2010 May 21;10:221. doi: 10.1186/1471-2407-10-221.

PMID:
20487573
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.

Chen X, Wang H, Xie W, Liang R, Wei Z, Zhi L, Zhang X, Hao B, Zhong S, Zhou G, Zhang L, Gao X, Zhu Y, He F.

Pharmacogenet Genomics. 2006 Mar;16(3):219-27.

PMID:
16495781
[PubMed - indexed for MEDLINE]
20.

Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study.

Li Y, Wang J, Jiang F, Lin W, Meng W.

BMC Med Genet. 2012 Jan 3;13:1. doi: 10.1186/1471-2350-13-1.

PMID:
22214342
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk